UDP-(5F) -GlcNAc作为MshA的缓慢结合抑制剂,一种保留糖转移酶
Patrick A Frantom1, James K Coward, John S Blanchard
1Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA. pfrantom@bama.ua.edu
Journal of the American Chemical Society
|April 24, 2010
概括
研究人员发现了一种新的慢结合抑制剂,用于糖转移酶酶. 这一发现为设计针对这些治疗相关酶的药物提供了新的策略.
科学领域:
- 生物化学 生化学
- 酶学 是一种酶学.
- 药物发现 药物发现 药物发现
背景情况:
- 糖转移酶酶在细胞过程中至关重要.
- 有效的甘氨基基转移酶抑制剂很少,限制了治疗应用.
研究的目的:
- 为了识别和表征新型的抑制剂,用于糖转移酶酶.
- 为了研究一种特定的糖系转移酶的抑制机制,MshA.
主要方法:
- 进行了酶动力学测试.
- 使用UDP-(5F) -GlcNAc作为MshA.的潜在抑制剂.
- 分析了动力学数据,以确定抑制机制和常数.
主要成果:
- UDP-(5F) -GlcNAc证明了MshA.的缓慢结合,竞争性抑制.
- 抑制机制被确定为单步,缓慢平衡.
- 这些发现支持了氧化碳过渡状态结构的参与.
结论:
- 这是第一个报告的缓慢发作抑制剂,用于糖转移酶家族.
- 结果表明,设计针对GT-B糖系转移酶的抑制剂的新途径.
- 了解酶结构是未来抑制剂设计的关键.
相关概念视频
Oligosaccharide Assembly
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...

